HomeNewsBusinessEconomyExtend one-time restructuring of MSME advances until March 31 next year, FIDC tells RBI

Extend one-time restructuring of MSME advances until March 31 next year, FIDC tells RBI

The Finance Industry Development Council has sought the inclusion of 'retail trade' and 'wholesale trade' as activities recognised by the Ministry of MSMEs for registration.

April 20, 2021 / 21:29 IST
Story continues below Advertisement
Retail Sector | Representative Image (PC-Shutterstock)
Retail Sector | Representative Image (PC-Shutterstock)

In the wake of the second wave of COVID-19 in the country, Finance Industry Development Council (FIDC) urged the Reserve Bank of India (RBI) Governor Shaktikanta Das to consider extending the one-time restructuring of MSME advances till March 31, 2022.

The council, in its letter to the RBI governor, informed that MSMEs and the retail and wholesale trader industry have not been able to revive their economic activities and, therefore, are in urgent need of support from lenders.

Story continues below Advertisement

"Various surveys and reports are forewarning that the operating environment for banks will most likely remain challenging, as the second wave could dent the sluggish recovery in consumer and corporate confidence, and further suppress banks’ prospects for new business. Considering the challenging environment for MSMEs and lenders, it will be helpful if the RBI extends the said notification till at least March 31, 2022,” FIDC Director-General Mahesh Thakkar said in the letter.

NBFCs seek extension of MSME restructuring scheme until March 2022

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show